Wilkins Owen M, Downey Sondra L, Weyburne Emily S, Williams David A, Mirabella Anne C, Overkleeft Herman S, Kisselev Alexei F
Department of Pharmacology and Toxicology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, NH 03756, USA.
Leiden Institute of Chemistry and Netherlands Proteomics Centre, Gorlaeus Laboratories, 2333 CC Leiden, The Netherlands.
Anal Biochem. 2014 Apr 15;451:1-3. doi: 10.1016/j.ab.2014.01.009. Epub 2014 Jan 29.
Proteasome-Glo is a homogeneous cell-based assay of proteasomal chymotrypsin-like, trypsin-like, and caspase-like activities using luminogenic substrates, commercially available from Promega. Here we report that the background activity from cleavage of the substrate of the trypsin-like sites by nonproteasomal proteases in multiple breast and lung cancer cell lines exceeds the activity of the proteasome. We also observed substantial background chymotrypsin-like activity in some cell lines. Thus, Proteasome-Glo assay must be used with caution, and it is necessary to include a specific proteasome inhibitor to determine the background for each proteasome activity.
蛋白酶体发光检测法是一种基于细胞的均质检测方法,用于检测蛋白酶体的类胰凝乳蛋白酶、类胰蛋白酶和类半胱天冬酶活性,使用的是发光底物,可从普洛麦格公司商业购得。在此我们报告,在多种乳腺癌和肺癌细胞系中,非蛋白酶体蛋白酶对类胰蛋白酶位点底物的切割产生的背景活性超过了蛋白酶体的活性。我们还在一些细胞系中观察到了大量的背景类胰凝乳蛋白酶活性。因此,使用蛋白酶体发光检测法时必须谨慎,并且有必要加入一种特异性蛋白酶体抑制剂来确定每种蛋白酶体活性的背景值。